Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19
NCT04338360 · Status: APPROVED_FOR_MARKETING · Type: EXPANDED_ACCESS
Last updated 2020-09-02
Summary
This expanded access program will provide access to investigational convalescent plasma for patients in acute care facilities infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Conditions
- COVID19
Interventions
- BIOLOGICAL
-
COVID-19 convalescent plasma
COVID-19 convalescent plasma
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Michael Joyner, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Convalescent Plasma Therapy for COVID-19 Patients
NCT04565197 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Extracorporeal Blood Purification as a Treatment Modality for COVID-19
NCT04478539 ·Status: COMPLETED
-
Convalescent Plasma for COVID-19 Research Donor Study
NCT04555109 ·Status: UNKNOWN
-
Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers
NCT04334876 ·Status: COMPLETED ·Phase: NA
-
Donated Antibodies Working Against nCoV
NCT04429854 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device
NCT04595903 ·Status: TERMINATED ·Phase: NA
-
COVID-19 Recovered Volunteer Research Participant Pool Registry
NCT04359602 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
NCT05669261 ·Status: UNKNOWN ·Phase: PHASE1
-
T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19
NCT05798260 ·Status: WITHDRAWN
-
Acquiring Convalescent Specimens for COVID-19 Antibodies
NCT04342195 ·Status: COMPLETED
-
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764 ·Status: UNKNOWN
-
SARS-CoV-2 Nucleic Acid Detection Kit Clinical Performance Study
NCT05492227 ·Status: COMPLETED
-
Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
NCT04667442 ·Status: COMPLETED
-
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19
NCT04403035 ·Status: WITHDRAWN
-
New Reusable Mask Design With Superior Filtration and Fit
NCT04826809 ·Status: COMPLETED ·Phase: NA
-
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
NCT04818970 ·Status: COMPLETED ·Phase: NA
-
Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 Vaccine
NCT05315362 ·Status: UNKNOWN ·Phase: PHASE2
-
Site Selection for Intracutaneous Saline Delivery
NCT01767324 ·Status: COMPLETED ·Phase: NA
-
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
NCT04368897 ·Status: WITHDRAWN
-
Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis
NCT05647096 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood
NCT05338762 ·Status: COMPLETED
-
Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19
NCT04662671 ·Status: COMPLETED ·Phase: NA
-
Healthy Volunteer COVID-19 Antibody Testing Study
NCT04529460 ·Status: WITHDRAWN
-
A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host-Microbe Scientific Study
NCT00764023 ·Status: COMPLETED
-
Study the Average Aerobic Bioburden Levels on Catheters After Use With Egret Catheter and the Predicate Device
NCT01124578 ·Status: COMPLETED